NCT05369403 · Interventional trial
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Dermatology and Skin Surgery Center, PC · Exton, PA · Chester County
- Windsor Dermatology, P.C. · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory